Intermountain operating income up 77% in 1st half of 2024

Salt Lake City-based Intermountain Health reported an operating income of $326 million (3.8% margin) over the first half of 2024, up from an operating income of $184 million (2.3% margin) over the same period last year, according to its Aug. 28 financial report.

Advertisement

Intermountain posted revenues of $8.5 billion in the six months ended June 30, up from $7.9 billion posted over the same period in 2023. Patient service revenues were $5.1 billion, up from $4.7 billion. 

The health system reported $7.8 billion in expenses in the first half of 2024, up from $7.4 billion posted over the same period last year. Employee compensation and benefits totaled $3.6 billion, up from $3.4 billion. Supply expenses totaled $1.5 billion, up from $1.4 billion. Medical claims totaled $1.5 billion, up from $1.3 billion. 

After accounting for nonoperating items such as investment income, Intermountain reported a net income of $1.12 billion for the first six months of 2024, up from $1.06 billion over the same period last year.   

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

  • Baylor College of Medicine and Texas Children’s Hospital established an affiliation more than 70 years ago in the Texas Medical…

  • Fitch revised Ontario, Calif.-based Prime Healthcare Services’ outlook to positive and affirms its “B” rating.  The revised outlook reflects Fitch’s…

  • Brentwood, Tenn.-based Lifepoint Health, a health system owned by private equity firm Apollo Global Management, has largely grown over the…

Advertisement

Comments are closed.